Company Long-Term Indebtedness: Aspira Women's Health, Inc. (AWH)

Public company logo of Vermillion (AWH)

Aspira Women's Health (AWH) localizes sample processing but relies on external cloud capacities for bioinformatics, which this price chart confirms with the 0.00 indicator. The business leverages advanced protein markers for the early detection of female oncological diseases. A strong team of R&D experts and molecular research automation engineers dedicated to the company's mission ensures stable development.

AWH aspirawh.com: Company Long-Term Debt in the range 07/04/2022 - 04/26/2025

Summary analytical data breakdowns for Vermillion (AWH)

- market price and analyst price targets:
Stock Price aspirawh.com|AWH - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Aspira Women's Health|AWH - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Aspira Women's Health|AWH - Company Book Value|Market Value to Book Value Ratio aspirawh.com|AWH - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Capital Aspira Women's Health|AWH - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Aspira Women's Health Inc|AWH - Company Aggregate Debts|Debts to Net Assets Aspira Women's Health|AWH - Company Long-Term Debt|Short-Term Debt Volume Aspira Women's Health|Quick Ratio aspirawh.com
- business earnings and investment ratios data:
AWH - Company Net Income
Summary company analytics:AWH aspirawh.com
Manufactured product of Aspira Women's Health

Investors are searching Aspira Women's Health (AWH) financial statements for fundamental solvency markers. This metric measures the aggregate of credit obligations with maturities exceeding one year, reflecting the long-term financial burden. By analyzing the company's long-term debt statistics, one can assess loan service rates outside of quarterly cycles. For Aspira Women's Health, this balance is critical amid fluctuations in insurance reimbursements for diagnostics. A stable borrowing level confirms the existence of a safety cushion for business development.

Competitors of Aspira Women's Health (AWH)

Company Long-Term Debts agilent.com A|DGX - Company Long-Term Debt|ILMN (Illumina Inc) - Company Long-Term Indebtedness|EXAS: Company Long-Term Debts|Revvity Corp (RVTY) - Company Long-Term Debts|Company Long-Term Debt Bio-Rad Laboratories|Company Long-Term Debt NNNN|Company Long-Term Liabilities SHC (Sotera Health)|QDEL - Long-Term Debt|Company Long-Term Debt OPKO Corp OPK|Long-Term Debt Volume CareDx (CDNA)|Maravai LifeSciences - Company Long-Term Debts|Long-Term Debt Volume fulgentgenetics.com FLGT|Standard BioTools (LAB) - Company Long-Term Debt|CTKB - Long-Term Debt Volume|OSUR (OraSure Technologies Inc) - Company Long-Term Debts|Company Long-Term Debts Exagen Diagnostics|Company Long-Term Debt MDxHealth SA (MDXH)|Long-Term Debt Volume luciddx.com|Company Long-Term Debt Prenetics PRE|IMDX (Insight Molecular Diagnostics, Inc.) - Long-Term Liabilities|Trinity Biotech Corp - Company Long-Term Debts|Long-Term Debt Volume ProPhase Labs Corp PRPH|Ainos, Inc. (AIMD) - Company Long-Term Debt|codiagnostics.com - Company Long-Term Loans and Borrowings|HSCS (HeartSciences) - Company Long-Term Debts|Company Long-Term Debts Biomerica Inc.|Company Long-Term Liabilities CDIO (Cardio Diagnostics)|VRAX (Virax Biolabs Corp) - Company Long-Term Loans and Borrowings|Bluejay Diagnostics - Company Long-Term Liabilities|AXDX - Company Long-Term Liabilities|CNTG - Company Long-Term Debt|Long-Term Debt Enzo Biochem, Inc.|fresh2.co (FRES) - Company Long-Term Debt|Company Long-Term Liabilities Genetic Technologies Limited|ME (23andMe Holding Co.) - Company Long-Term Debts|Long-Term Debt psychemedics.com PMD